欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2102/001
药品名称Melatonin Bluefish
活性成分
    • Melatonin 2.0 mg
剂型Prolonged-release tablet
上市许可持有人Bluefish Pharmaceuticals AB, Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Austria (AT)
    • Germany (DE)
    • Denmark (DK)
    • Spain (ES)
    • Finland (FI)
    • France (FR)
    • Ireland (IE)
    • Iceland (IS)
    • Norway (NO)
      Melatonin Bluefish
    • Portugal (PT)
    • United Kingdom (Northern Ireland) (XI)
许可日期2022/07/01
最近更新日期2023/03/30
药物ATC编码
    • N05CH01 melatonin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    撤市原因:1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised.
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase